Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression

- Group I PAKs are critical for development, plasticity, and maturation of the nervous system.
- PAK1 and PAK3 but not PAK2 mRNA levels alter in the PFC and the hippocampus of depressed subjects respectively.
- mRNA levels of PAKs activators: RAC1, CDC42, and ARHGEF7 are not affected in these brain regions.
- Coexpression of the group I PAKs and of their activators alters in the brain of depressed subjects.
- Dysregulated PAK1/PAK3 signaling associates with human depression.

The p21-activated kinases (PAKs) of group I are the main effectors for the small Rho GTPases, critically involved in neurodevelopment, plasticity and maturation of the nervous system. Moreover, the neuronal complexity controlled by PAK1/PAK3 signaling determines the postnatal brain size and synaptic properties. Stress induces alterations at the level of structural and functional synaptic plasticity accompanied by reductions in size and activity of the hippocampus and the prefrontal cortex (PFC). These abnormalities are likely to contribute to the pathology of depression and, in part, reflect impaired cytoskeleton remodeling pointing to the role of Rho GTPase signaling. Thus, the present study assessed the expression of the group I PAKs and their activators in the brain of depressed subjects. Using quantitative polymerase chain reaction (qPCR), mRNA levels and coexpression of the group I PAKs: PAK1, PAK2, and PAK3 as well as of their activators: RAC1, CDC42 and ARHGEF7 were examined in postmortem samples from the PFC (n = 25) and the hippocampus (n = 23) of subjects with depression and compared to control subjects (PFC n = 24; hippocampus n = 21). Results demonstrated that mRNA levels of PAK1 and PAK3, are significantly reduced in the brain of depressed subjects, with PAK1 being reduced in the PFC and PAK3 in the hippocampus. No differences were observed for the ubiquitously expressed PAK2. Following analysis of gene coexpression demonstrated disruption of coordinated gene expression in the brain of subjects with depression. Abnormalities in mRNA expression of PAK1 and PAK3 as well as their altered coexpression patterns were detected in the brain of subjects with depression.

275